Zamann Pharma Support logo

Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Request an appointment now

U.S. and China AI Drug Race Is Breaking Regulatory Control; FDA Pressure and Data Failures Are Escalating Fast

At BioSpace’s NextGen 2026 discussion, leading biotech executives from the United States and China highlighted a growing strategic divide in pharmaceutical innovation. The conversation revealed how artificial intelligence is now accelerating drug discovery and clinical decision-making, while simultaneously exposing weaknesses
  • News
U.S. and China AI Drug Race Is Breaking Regulatory Control; FDA Pressure and Data Failures Are Escalating Fast

FDA Real-Time Clinical Trials Shock Pharma Industry, Expose Hidden Compliance Risks Across Systems

The FDA has launched a real-time clinical trial monitoring initiative in the United States, enabling regulators to access live trial data to accelerate drug development and approval. Reported by PharmaVoice on May 13, 2026, the move highlights a growing shift
  • News
FDA Real-Time Clinical Trials Shock Pharma Industry, Expose Hidden Compliance Risks Across Systems